Intranasal Human FGF-1 for Subjects With Parkinson's Disease

NCT05493462 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

4

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: Human FGF-1

Sponsor

Zhittya Genesis Medicine, Inc.